For high-risk patients, the method could offer a safer alternative to open-heart surgery.
In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.
BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of ...
The Global Vagus Nerve Stimulation Market Size projected to grow at a CAGR of 10.50% from 2024 to 2031, according to a new ...
The global near-infrared (NIR) imaging market is projected to grow at a CAGR of approximately 7–8% over the next five years. This growth is driven by the rising burden of chronic diseases, the ...
Robotic surgery is reshaping modern medicine. A combination of robotics and advanced imaging technologies allows surgeons to ...
Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback